Clinical trial
Quality of Life After Primary Transoral Robotic Surgery vs Intensity-modulated Radiotherapy for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma: A Randomized National Trial
NCT04124198 is registered in ClinicalTrials.gov with Christian von Buchwald as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Quality of Life After Primary Transoral Robotic Surgery vs Intensity-modulated Radiotherapy for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma: A Randomized National Trial
- Lead sponsor
- Christian von Buchwald
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- March 1, 2019
- Completion date
- December 31, 2029
- Enrollment
- 138 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
carcinoma, carcinoma, squamous cell, dna virus infections, head and neck neoplasms, neoplasms by histologic type, neoplasms by site, neoplasms, glandular and epithelial, neoplasms, squamous cell, oropharyngeal neoplasms, oropharynx cancer, oropharynx squamous cell carcinoma, otorhinolaryngologic diseases, otorhinolaryngologic neoplasms, papillomavirus infections, pharyngeal diseases, pharyngeal neoplasms malignant and unspecified, quality of life, tumor virus infections, virus diseases